242 related articles for article (PubMed ID: 29898743)
1. Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review.
Tricco AC; Zarin W; Lillie E; Jeblee S; Warren R; Khan PA; Robson R; Pham B; Hirst G; Straus SE
BMC Med Inform Decis Mak; 2018 Jun; 18(1):38. PubMed ID: 29898743
[TBL] [Abstract][Full Text] [Related]
2. Utility of social media and crowd-sourced data for pharmacovigilance: a scoping review protocol.
Tricco AC; Zarin W; Lillie E; Pham B; Straus SE
BMJ Open; 2017 Jan; 7(1):e013474. PubMed ID: 28104709
[TBL] [Abstract][Full Text] [Related]
3. Adverse Drug Reaction Identification and Extraction in Social Media: A Scoping Review.
Lardon J; Abdellaoui R; Bellet F; Asfari H; Souvignet J; Texier N; Jaulent MC; Beyens MN; Burgun A; Bousquet C
J Med Internet Res; 2015 Jul; 17(7):e171. PubMed ID: 26163365
[TBL] [Abstract][Full Text] [Related]
4. Eliciting adverse effects data from participants in clinical trials.
Allen EN; Chandler CI; Mandimika N; Leisegang C; Barnes K
Cochrane Database Syst Rev; 2018 Jan; 1(1):MR000039. PubMed ID: 29372930
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts.
Pierce CE; Bouri K; Pamer C; Proestel S; Rodriguez HW; Van Le H; Freifeld CC; Brownstein JS; Walderhaug M; Edwards IR; Dasgupta N
Drug Saf; 2017 Apr; 40(4):317-331. PubMed ID: 28044249
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Navigating duplication in pharmacovigilance databases: a scoping review.
Kiguba R; Isabirye G; Mayengo J; Owiny J; Tregunno P; Harrison K; Pirmohamed M; Ndagije HB
BMJ Open; 2024 Apr; 14(4):e081990. PubMed ID: 38684275
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Adverse Drug Events in Web Forums: Evaluation of a Pipeline and Use Case Study.
Karapetiantz P; Audeh B; Redjdal A; Tiffet T; Bousquet C; Jaulent MC
J Med Internet Res; 2024 Jun; 26():e46176. PubMed ID: 38888956
[TBL] [Abstract][Full Text] [Related]
9. The Use of Social Media in Detecting Drug Safety-Related New Black Box Warnings, Labeling Changes, or Withdrawals: Scoping Review.
Lee JY; Lee YS; Kim DH; Lee HS; Yang BR; Kim MG
JMIR Public Health Surveill; 2021 Jun; 7(6):e30137. PubMed ID: 34185021
[TBL] [Abstract][Full Text] [Related]
10. Social Media Listening for Routine Post-Marketing Safety Surveillance.
Powell GE; Seifert HA; Reblin T; Burstein PJ; Blowers J; Menius JA; Painter JL; Thomas M; Pierce CE; Rodriguez HW; Brownstein JS; Freifeld CC; Bell HG; Dasgupta N
Drug Saf; 2016 May; 39(5):443-54. PubMed ID: 26798054
[TBL] [Abstract][Full Text] [Related]
11. Can social media data lead to earlier detection of drug-related adverse events?
Duh MS; Cremieux P; Audenrode MV; Vekeman F; Karner P; Zhang H; Greenberg P
Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1425-1433. PubMed ID: 27601271
[TBL] [Abstract][Full Text] [Related]
12. The Role of Social Media for Identifying Adverse Drug Events Data in Pharmacovigilance: Protocol for a Scoping Review.
Golder S; O'Connor K; Wang Y; Gonzalez Hernandez G
JMIR Res Protoc; 2023 Aug; 12():e47068. PubMed ID: 37531158
[TBL] [Abstract][Full Text] [Related]
13. Utilizing social media data for pharmacovigilance: A review.
Sarker A; Ginn R; Nikfarjam A; O'Connor K; Smith K; Jayaraman S; Upadhaya T; Gonzalez G
J Biomed Inform; 2015 Apr; 54():202-12. PubMed ID: 25720841
[TBL] [Abstract][Full Text] [Related]
14. Social Media Analytics for Pharmacovigilance of Antiepileptic Drugs.
Yahya AA; Asiri Y; Alyami I
Comput Math Methods Med; 2022; 2022():8965280. PubMed ID: 35027943
[TBL] [Abstract][Full Text] [Related]
15. BERT-based language model for accurate drug adverse event extraction from social media: implementation, evaluation, and contributions to pharmacovigilance practices.
Dong F; Guo W; Liu J; Patterson TA; Hong H
Front Public Health; 2024; 12():1392180. PubMed ID: 38716250
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
[TBL] [Abstract][Full Text] [Related]
17. Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature.
Sartori D; Aronson JK; Onakpoya IJ
Syst Rev; 2020 Aug; 9(1):180. PubMed ID: 32791982
[TBL] [Abstract][Full Text] [Related]
18. Comparison of drug safety data obtained from the monitoring system, literature, and social media: An empirical proof from a Chinese patent medicine.
Hu R; Golder S; Yang G; Li X; Wang D; Wang L; Xia R; Zhao N; Fang S; Lai B; Liu J; Fei Y
PLoS One; 2019; 14(11):e0222077. PubMed ID: 31693665
[TBL] [Abstract][Full Text] [Related]
19. A research framework for pharmacovigilance in health social media: Identification and evaluation of patient adverse drug event reports.
Liu X; Chen H
J Biomed Inform; 2015 Dec; 58():268-279. PubMed ID: 26518315
[TBL] [Abstract][Full Text] [Related]
20. Comparison of text processing methods in social media-based signal detection.
Gavrielov-Yusim N; Kürzinger ML; Nishikawa C; Pan C; Pouget J; Epstein LB; Golant Y; Tcherny-Lessenot S; Lin S; Hamelin B; Juhaeri J
Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1309-1317. PubMed ID: 31392844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
